• BX Home
  • Multiple Sclerosis: News [Page 3]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MULTIPLE SCLEROSIS

Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.

Multiple Sclerosis is part of Business Exchange, suggested by Steve McCarthy. This topic contains 967 news and 242 blog items. Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from like-minded professionals.

News

Please add new articles to this topic

Ministry Of Health Approves BrainStorm?s NurOwn? For The First Clinica...more

team headed by the principal investigator Prof. Dimitrios Karussis, M.D., Ph.D., Director of the Center for Multiple...

UPDATE 1- GW turns to profit, Sativex sales doublemore

for the drug, it said. Sativex, which is sprayed under the tongue as a treatment for spasticity in multiple sclerosis,...

10 year time capsule: "West Wing" and the furiesmore

Bartlet (Martin Sheen) attempted to come to grips with the death of a friend, the news of his multiple sclerosis...

Reportlinker Adds R&D Trends: Multiple Sclerosis - Progressive sub...more

in the increasingly diverse treatment algorithm. Your key questions answered * What are the key trends in the multiple...

> Adeona Pharmaceuticals reports bigger loss in 1st quartermore

a treatment for age-related macular degeneration and is conducting a 150-person trial of a drug to treat...

Pills Offer Easier Way to Treat MSmore

Extract not available.

Teva Seeks Control of Taiyo as Japan Pushes Generic Drugsmore

at $96 billion last year. Israel���s largest company is looking for new engines of growth as its multiple sclerosis...

A.M. Vitals: A New Wave of Multiple Sclerosis Medicines ��� in Pill Fo...more

Extract not available.

Teva to buy Taiyo stake for $460 million, bid for restmore

a $6.2 billion deal. Israel's largest company is looking for new engines of growth as its multiple sclerosis drug...

Avanir Pharmaceuticals To Present Data At The American Psychiatric Ass...more

emotional state. PBA outbursts result from a "short circuit" in the brain caused by another neurologic...

Sanofi deal may fetch up to $613 million for Glenmarkmore

of GBR 500, a biological drug for the treatment of Crohn���s Disease and other inflammatory conditions like multiple...

Teva Pharm to buy 57 percent of Taiyo for $460 millionmore

the world's biggest generic drugmaker reduce its dependence on U.S. generics and on Copaxone, its leading multiple...

Easier Way to Treat MSmore

Extract not available.

Adeona Reports 1st Quarter 2011 Financial Resultsmore

with our scientific advisors to determine what further clinical studies might be warranted to support additional...

Teva to Buy Taiyo Stake for $460 Million and Bid for Restmore

a $6.2 billion deal. Israel���s largest company is looking for new engines of growth as its multiple sclerosis drug...

I��ve hidden my MS from co-workersmore

health-care facilities with my team to determine potential space for patient care, but when we walked into the multiple...

Glenmark Sells Rights to New Drug to Sanofimore

Extract not available.

Glenmark to license new treatment to Sanofimore

SNY) The drug, codenamed GBR500, is aimed at treating Crohn's disease and other inflammatory conditions such as...

Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walk...more

fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients...

Biogen Idec Receives Approval For FAMPYRA In Australia To Improve Walk...more

fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients...

5 Stocks Under $10more

this month's picks. Elan (NYSE: ELN There are risks here. Tysabri is Elan's popular treatment for multiple sclerosis...

Glenmark in licensing deal with Sanofimore

on sales of products under the licence. The antibody, GBR500, used for the treatment of Crohn's disease, multiple...

As Adoption Deepens Among Prescribers, Satisfaction with Gilenya Remai...more

six months post launch, market share of Novartis' Gilenya, the newest disease-modifying agent (DMA) for the treatment...

Meredith Vieira 'will leave The Today Show in June and be replaced by ...more

said to be leaving for personal reasons. Vieira's husband, news journalist Richard Cohen continues to struggle with...

Toronto Marathon a test on two levelsmore

charity partners, including the Princess Margaret Hospital Foundation and groups dedicated to fighting various...

Top Sources: Multiple Sclerosis

  • St. Petersburg Times
  • Reuters
  • Chicago Tribune
  • Mail Online UK
  • MarketWatch
  • BBC
  • Boston Globe
  • Philadelphia Inquirer
  • BusinessWeek
  • Seattle Times

Most Active Users in this Topic

see all contributors in Multiple Sclerosis

Featured White Papers

Post a Job

Jobs in this Topic

Director Specialty Distribution Multiple Sclerosis Genzyme | Cambridge, MA
Posted: Mar 29
RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center Rush University Medical Center | Chicago, IL
Posted: May 14
Academic Multiple Sclerosis Opening in Midwest Jordan Medical Consultants | Springfield, IL
Posted: May 18
Multiple Sclerosis Nurse Educator Quintiles Transnational | Lansing, MI
Posted: May 20
Neurology - Multiple Sclerosis Physician Practicewisemd | Cincinnati, OH
Posted: Mar 30

Report comment contains invalid characters. ()
cancel
Search Cancel